The association between elevated expressed WNT5A and progression of melanoma (Weeraratna et al., 2002) and lung cancer (Wang et al., 2017), breast cancer (Prasad et al., 2018), and prostate cancer (Lee et al., 2018) was reported. This evidence concerns the gene WNT5A and Familial prostate cancer.